Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Science Translational Medicine
|
February 14, 2014
From silos to multilingual science
Syril D Pettit
Environmental Health Perspectives
|
September 4, 2004
Toxicogenomics in risk assessment: communicating the challenges
Syril D Pettit
Regulatory Toxicology and Pharmacology : RTP
|
December 25, 2023
A (not) new Rx: Quality Improvement for NAM
Syril D Pettit
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
January 28, 2021
ToxPoint: Health Disparities, COVID-19, and Owning Our Share
Syril D Pettit
Cardio-Oncology (London, England)
|
March 11, 2020
Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors?
Syril D Pettit, Rebecca Kirch
Environmental Health Perspectives
|
March 23, 2004
Toxicogenomics in risk assessment: an overview of an HESI collaborative research program
William Pennie, Syril D Pettit, Peter G Lord
Journal of Pharmacological and Toxicological Methods
|
May 15, 2009
A HESI consortium approach to assess the human predictive value of non-clinical repolarization assays
Elena S Trepakova, John Koerner, Syril D Pettit, et al.
Environmental Health Perspectives
|
March 23, 2004
Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression
Roger G Ulrich, John C Rockett, G Gordon Gibson, et al.
Environmental Health Perspectives
|
March 23, 2004
Database development in toxicogenomics: issues and efforts
William B Mattes, Syril D Pettit, Susanna-Assunta Sansone, et al.
Cancer
|
August 28, 2019
Stakeholder perspectives on addressing adverse events from adjuvant cancer therapy: A qualitative study
Syril D Pettit, Pamela Silberman, Kristen Hassmiller Lich, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Science Translational Medicine
|
February 14, 2014
From silos to multilingual science
Syril D Pettit
Environmental Health Perspectives
|
September 4, 2004
Toxicogenomics in risk assessment: communicating the challenges
Syril D Pettit
Regulatory Toxicology and Pharmacology : RTP
|
December 25, 2023
A (not) new Rx: Quality Improvement for NAM
Syril D Pettit
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
January 28, 2021
ToxPoint: Health Disparities, COVID-19, and Owning Our Share
Syril D Pettit
Cardio-Oncology (London, England)
|
March 11, 2020
Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors?
Syril D Pettit, Rebecca Kirch
Environmental Health Perspectives
|
March 23, 2004
Toxicogenomics in risk assessment: an overview of an HESI collaborative research program
William Pennie, Syril D Pettit, Peter G Lord
Journal of Pharmacological and Toxicological Methods
|
May 15, 2009
A HESI consortium approach to assess the human predictive value of non-clinical repolarization assays
Elena S Trepakova, John Koerner, Syril D Pettit, et al.
Environmental Health Perspectives
|
March 23, 2004
Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression
Roger G Ulrich, John C Rockett, G Gordon Gibson, et al.
Environmental Health Perspectives
|
March 23, 2004
Database development in toxicogenomics: issues and efforts
William B Mattes, Syril D Pettit, Susanna-Assunta Sansone, et al.
Cancer
|
August 28, 2019
Stakeholder perspectives on addressing adverse events from adjuvant cancer therapy: A qualitative study
Syril D Pettit, Pamela Silberman, Kristen Hassmiller Lich, et al.
Page
of 3